(ASRT) Assertio Therapeutics - Performance -53.5% in 12m
ASRT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-76.77%
#153 in Peer-Group
Rel. Strength
8.11%
#7073 in Stock-Universe
Total Return 12m
-53.48%
#166 in Peer-Group
Total Return 5y
-78.75%
#137 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 15.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 1.75 USD |
| 52 Week Low | 0.53 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 86.46 |
| Buy/Sell Signal +-5 | 1.84 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ASRT (-53.5%) vs XLV (-4.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.42% | 131% | 313% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.1% | 16.7% | 81% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
0.51% | -14.7% | 405% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.14% | 4.1% | 53.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.82% | 3.79% | 51.6% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-8.26% | -8.24% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.1% | -7.38% | 46.1% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| UCB BR UCB |
5.98% | 19.9% | 66.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: ASRT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ASRT
| Total Return (including Dividends) | ASRT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 4.62% | 1.09% | 3.75% |
| 3 Months | 28.91% | 1.98% | 25.32% |
| 12 Months | -53.48% | -4.84% | 13.11% |
| 5 Years | -78.75% | 45.05% | 109.78% |
| Trend Score (consistency of price movement) | ASRT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 6.8% | 20.4% | 80.3% |
| 3 Months | 56.1% | -22.1% | 97.2% |
| 12 Months | -95.5% | -76.5% | 45.4% |
| 5 Years | -50.3% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th70.50 | 3.49% | 0.84% |
| 3 Month | %th64.00 | 26.40% | 2.86% |
| 12 Month | %th17.50 | -51.11% | -58.87% |
| 5 Years | %th30.00 | -85.35% | -89.87% |
FAQs
Does Assertio Therapeutics (ASRT) outperform the market?
No,
over the last 12 months ASRT made -53.48%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.84%.
Over the last 3 months ASRT made 28.91%, while XLV made 1.98%.
Performance Comparison ASRT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ASRT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.1% | 0.9% | -23% | -67% |
| US NASDAQ 100 | QQQ | 6.6% | 0.4% | -24.6% | -65% |
| German DAX 40 | DAX | 5.3% | 4.4% | -35.8% | -84% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.1% | 0.9% | -26.7% | -75% |
| Hongkong Hang Seng | HSI | 7.6% | 1.6% | -43.5% | -92% |
| India NIFTY 50 | INDA | 7.9% | 3.8% | -23.5% | -53% |
| Brasil Bovespa | EWZ | 7.9% | -1.3% | -45% | -61% |
ASRT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8.5% | 1.1% | -27.5% | -78% |
| Consumer Discretionary | XLY | 7.9% | 2.6% | -15.2% | -69% |
| Consumer Staples | XLP | 8.4% | 4.2% | -23.5% | -61% |
| Energy | XLE | 4% | -2.2% | -19.3% | -56% |
| Financial | XLF | 8.4% | 1.9% | -25.6% | -81% |
| Health Care | XLV | 8.9% | 3.5% | -14.1% | -49% |
| Industrial | XLI | 7% | 1.5% | -29.9% | -78% |
| Materials | XLB | 6.3% | 0.9% | -26.6% | -59% |
| Real Estate | XLRE | 8.3% | 4.8% | -21.9% | -65% |
| Technology | XLK | 5.5% | -2.6% | -27.1% | -64% |
| Utilities | XLU | 8.6% | 3.3% | -25.4% | -75% |
| Aerospace & Defense | XAR | 6.4% | 0.8% | -41.2% | -101% |
| Biotech | XBI | 5.6% | 4.1% | -8.9% | -44% |
| Homebuilder | XHB | 8.4% | -1.4% | -15.1% | -57% |
| Retail | XRT | 7.1% | 3.1% | -18.3% | -63% |
ASRT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.5% | -2.19% | -16.7% | -49% |
| Natural Gas | UNG | 9.4% | 15.1% | -3.8% | -47% |
| Gold | GLD | 8.7% | 5.4% | -40.8% | -93% |
| Silver | SLV | 5.9% | 4.9% | -38.6% | -72% |
| Copper | CPER | 0.6% | -5.5% | -43.4% | -72% |
ASRT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 10% | 3.6% | -19.3% | -50% |
| iShares High Yield Corp. Bond | HYG | 7.8% | 3.3% | -21.4% | -63% |